IMPACT OF TYROSINE KINASE INHIBITORS ON MINIMAL RESIDUAL DISEASE AND OUTCOME IN CHILDHOOD PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

BACKGROUND: BCR-ABL1 tyrosine kinase inhibitors (TKIs) improve the outcome of childhood Philadelphia-chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) when incorporated into post-remission induction chemotherapy. No data is available on the impact of TKIs on end of induction minimal residua...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer
Hoofdauteurs: Jeha, Sima, Coustan-Smith, Elaine, Pei, Deqing, Sandlund, John T., Rubnitz, Jeffrey E., Howard, Scott C., Inaba, Hiroto, Bhojwani, Deepa, Metzger, Monika L., Cheng, Cheng, Choi, John K., Jacobsen, Jeffrey, Shurtleff, Sheila A., Raimondi, Susana, Ribeiro, Raul C., Pui, Ching-Hon, Campana, Dario
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249731/
https://ncbi.nlm.nih.gov/pubmed/24501014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28598
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items